AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. AHCO
  4. [Form 4] AdaptHealth Corp. Insider Trading Activity

[Form 4] AdaptHealth Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

AdaptHealth Corp. (AHCO) filed a Form 4 reporting that director Bradley J. Coppens acquired 21,346 shares of common stock on 06/26/2025. The shares were recorded at a stated price of $0.00, indicating a grant or other non-cash issuance. Following the transaction, Coppens鈥� direct ownership stands at 77,346 AHCO shares. No derivative securities were reported, and no other officers or insiders were listed on this filing.

AdaptHealth Corp. (AHCO) ha presentato un Modulo 4 segnalando che il direttore Bradley J. Coppens ha acquisito 21.346 azioni di azioni ordinarie il 26/06/2025. Le azioni sono state registrate a un prezzo dichiarato di $0,00, indicando una concessione o un'altra emissione non in contanti. Dopo la transazione, la propriet脿 diretta di Coppens ammonta a 77.346 azioni AHCO. Non sono stati segnalati titoli derivati e nessun altro dirigente o insider 猫 stato elencato in questa dichiarazione.

AdaptHealth Corp. (AHCO) present贸 un Formulario 4 informando que el director Bradley J. Coppens 补诲辩耻颈谤颈贸 21,346 acciones de acciones comunes el 26/06/2025. Las acciones se registraron a un precio declarado de $0.00, lo que indica una concesi贸n u otra emisi贸n no monetaria. Tras la transacci贸n, la propiedad directa de Coppens es de 77,346 acciones de AHCO. No se reportaron valores derivados ni se listaron otros funcionarios o insiders en esta presentaci贸n.

AdaptHealth Corp. (AHCO)電� 鞚挫偓 Bradley J. Coppens臧赌 2025雲� 6鞗� 26鞚�鞐� 21,346欤�鞚� 氤错喌欤茧ゼ 旆摑頄堧嫟瓿� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟. 欤检嫕鞚� $0.00鞚� 氇呾嫓霅� 臧赌瓴╈溂搿� 旮半霅橃柎, 氤挫“旮� 霕愲姅 旮绊儉 順勱笀鞚� 鞎勲媽 氚滍枆鞛勳潉 雮橅儉雰呺媹雼�. 瓯半灅 頉� Coppens鞚� 歆侅爲 靻岇湢 欤检嫕鞚� 77,346欤� AHCO搿� 鞙犾霅╇媹雼�. 韺岇儩 歃濌秾鞚� 氤搓碃霅橃 鞎婌晿鞙茧┌, 鞚� 鞝滌稖靹滌棎電� 雼るジ 鞛勳洂鞚措倶 雮措秬鞛愱岸� 旮办灛霅橃 鞎婌晿鞀惦媹雼�.

AdaptHealth Corp. (AHCO) a d茅pos茅 un formulaire 4 indiquant que le directeur Bradley J. Coppens a acquis 21 346 actions ordinaires le 26/06/2025. Les actions ont 茅t茅 enregistr茅es 脿 un prix d茅clar茅 de 0,00 $, ce qui indique une attribution ou une autre 茅mission non mon茅taire. Suite 脿 la transaction, la d茅tention directe de Coppens s'茅l猫ve 脿 77 346 actions AHCO. Aucun titre d茅riv茅 n'a 茅t茅 signal茅 et aucun autre dirigeant ou initi茅 n'a 茅t茅 mentionn茅 dans ce d茅p么t.

AdaptHealth Corp. (AHCO) reichte ein Formular 4 ein, in dem berichtet wird, dass Direktor Bradley J. Coppens am 26.06.2025 21.346 Aktien von Stammaktien erworben hat. Die Aktien wurden zu einem angegebenen Preis von 0,00 $ verbucht, was auf eine Zuwendung oder eine andere nicht zahlungswirksame Ausgabe hinweist. Nach der Transaktion h盲lt Coppens direkt 77.346 AHCO-Aktien. Es wurden keine Derivate gemeldet, und keine weiteren leitenden Angestellten oder Insider wurden in dieser Meldung aufgef眉hrt.

Positive
  • Insider acquisition: Director Bradley Coppens received 21,346 shares, lifting his direct stake to 77,346 shares, modestly aligning insider and shareholder interests.
Negative
  • None.

Insights

TL;DR: Small, non-cash insider share grant; marginally positive signal, immaterial to overall float.

The filing shows a routine equity grant to Director Bradley Coppens, increasing his stake to 77,346 shares. While insider accumulation is generally viewed favorably, the 21,346-share addition is minor relative to AdaptHealth鈥檚 total shares outstanding and therefore unlikely to move the stock. No derivatives, sales, or 10b5-1 plan usage were disclosed, limiting interpretive complexity. Overall impact is neutral from a valuation perspective but incrementally positive for governance alignment.

AdaptHealth Corp. (AHCO) ha presentato un Modulo 4 segnalando che il direttore Bradley J. Coppens ha acquisito 21.346 azioni di azioni ordinarie il 26/06/2025. Le azioni sono state registrate a un prezzo dichiarato di $0,00, indicando una concessione o un'altra emissione non in contanti. Dopo la transazione, la propriet脿 diretta di Coppens ammonta a 77.346 azioni AHCO. Non sono stati segnalati titoli derivati e nessun altro dirigente o insider 猫 stato elencato in questa dichiarazione.

AdaptHealth Corp. (AHCO) present贸 un Formulario 4 informando que el director Bradley J. Coppens 补诲辩耻颈谤颈贸 21,346 acciones de acciones comunes el 26/06/2025. Las acciones se registraron a un precio declarado de $0.00, lo que indica una concesi贸n u otra emisi贸n no monetaria. Tras la transacci贸n, la propiedad directa de Coppens es de 77,346 acciones de AHCO. No se reportaron valores derivados ni se listaron otros funcionarios o insiders en esta presentaci贸n.

AdaptHealth Corp. (AHCO)電� 鞚挫偓 Bradley J. Coppens臧赌 2025雲� 6鞗� 26鞚�鞐� 21,346欤�鞚� 氤错喌欤茧ゼ 旆摑頄堧嫟瓿� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟. 欤检嫕鞚� $0.00鞚� 氇呾嫓霅� 臧赌瓴╈溂搿� 旮半霅橃柎, 氤挫“旮� 霕愲姅 旮绊儉 順勱笀鞚� 鞎勲媽 氚滍枆鞛勳潉 雮橅儉雰呺媹雼�. 瓯半灅 頉� Coppens鞚� 歆侅爲 靻岇湢 欤检嫕鞚� 77,346欤� AHCO搿� 鞙犾霅╇媹雼�. 韺岇儩 歃濌秾鞚� 氤搓碃霅橃 鞎婌晿鞙茧┌, 鞚� 鞝滌稖靹滌棎電� 雼るジ 鞛勳洂鞚措倶 雮措秬鞛愱岸� 旮办灛霅橃 鞎婌晿鞀惦媹雼�.

AdaptHealth Corp. (AHCO) a d茅pos茅 un formulaire 4 indiquant que le directeur Bradley J. Coppens a acquis 21 346 actions ordinaires le 26/06/2025. Les actions ont 茅t茅 enregistr茅es 脿 un prix d茅clar茅 de 0,00 $, ce qui indique une attribution ou une autre 茅mission non mon茅taire. Suite 脿 la transaction, la d茅tention directe de Coppens s'茅l猫ve 脿 77 346 actions AHCO. Aucun titre d茅riv茅 n'a 茅t茅 signal茅 et aucun autre dirigeant ou initi茅 n'a 茅t茅 mentionn茅 dans ce d茅p么t.

AdaptHealth Corp. (AHCO) reichte ein Formular 4 ein, in dem berichtet wird, dass Direktor Bradley J. Coppens am 26.06.2025 21.346 Aktien von Stammaktien erworben hat. Die Aktien wurden zu einem angegebenen Preis von 0,00 $ verbucht, was auf eine Zuwendung oder eine andere nicht zahlungswirksame Ausgabe hinweist. Nach der Transaktion h盲lt Coppens direkt 77.346 AHCO-Aktien. Es wurden keine Derivate gemeldet, und keine weiteren leitenden Angestellten oder Insider wurden in dieser Meldung aufgef眉hrt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Coppens Bradley J
(Last) (First) (Middle)
C/O ONE EQUITY PARTNERS
510 MADISON AVENUE, 19TH FLOOR
(Street)
NEW YORK NY 10022
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 A 21,346 A $0 77,346 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney
/s/ Richard Rew, as attorney-in-fact for Bradley J. Coppens 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many AdaptHealth (AHCO) shares did Director Bradley J. Coppens acquire?

He acquired 21,346 shares of common stock.

What is Coppens鈥� total direct ownership in AHCO after the transaction?

His direct holdings increased to 77,346 shares.

What price was reported for the acquired shares?

The Form 4 lists a price of $0.00, indicating a non-cash grant.

Does the Form 4 include any derivative security transactions?

No, the filing reports no derivative securities acquired or disposed of.

When was the Form 4 for AdaptHealth (AHCO) filed?

The form was signed and filed on 06/30/2025.
Stock AHCO logo
Adapthealth Corp

NASDAQ:AHCO

AHCO Rankings

#3456 Ranked by Market Cap
N/A Ranked by Dividends

AHCO Latest News

Aug 4, 2025
AdaptHealth Corp. to Participate in Upcoming Investor Conference
Jul 15, 2025
AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call
Jun 30, 2025
AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt
May 13, 2025
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
May 6, 2025
AdaptHealth Corp. Announces First Quarter 2025 Results

AHCO Latest SEC Filings

Jun 30, 2025
[Form 4] AdaptHealth Corp. Insider Trading Activity
Jun 30, 2025
[Form 4] AdaptHealth Corp. Insider Trading Activity
Jun 30, 2025
[Form 4] AdaptHealth Corp. Insider Trading Activity
Jun 30, 2025
[Form 4] AdaptHealth Corp. Insider Trading Activity
Jun 30, 2025
[Form 4] AdaptHealth Corp. Insider Trading Activity

AHCO Stock Data

1.18B
108.76M
8.16%
102.48%
8.38%
Medical Devices
Services-home Health Care Services
United States
CONSHOHOCKEN